Clinical Trials Browser

Phase 1 × rocakinogene sifuplasmid × 90 days × Clear all

NCT04015700 2026-05-07

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Phase 1 Active not recruiting

9 enrolled 14 charts

Glioblastoma

NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular